Scholarlink

<p>Antimicrobial peptides (AMPs) are emerging as promising alternatives to traditional antibiotics against multidrug-resistant (MDR) bacteria. In this study, we isolated and characterized a novel AMP, named Hyde C1, from the chicory plant (<i>Cichorium intybus</i> L.). Hyde C1 was purified using reverse-phase high-performance liquid chromatography (RP-HPLC) and determined to have a molecular weight of 3686.4 Da. It exhibits strong antibacterial activity against both Gram-positive (<i>S. aureus</i> ATCC 29213) and Gram-negative (<i>E. coli</i> ATCC 25922, <i>P. aeruginosa</i> ATCC 27853, <i>A. baumannii</i> ATCC 19606) bacteria, with minimum inhibitory concentrations (MICs) ranging from 2 to 16&#xa0;µg/mL. Hyde C1 disrupts bacterial membranes, as evidenced by increased permeability, membrane depolarization, and scanning electron microscopy. Bioinformatic analysis revealed its amphipathic α-helical structure, with a high hydrophobic ratio (61%) and a net positive charge (+ 6), supporting its bactericidal mechanism. The peptide also demonstrated high stability under various pH, temperature, and salt conditions, along with low hemolytic and cytotoxic effects. These properties suggest that Hyde C1 is a strong candidate for development as a novel antimicrobial agent.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Discovery of hyde C1 a broad spectrum antimicrobial peptide derived from chicory

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月29日

查看全文
  • Samira Ghaderi Afshari,
  • Mehdi Goudarzi,
  • Fariba Sharifnia,
  • Mohaddeseh Larypoor,
  • Bahareh Hajikhani,
  • Sima Sadat Seyedjavadi

摘要

Antimicrobial peptides (AMPs) are emerging as promising alternatives to traditional antibiotics against multidrug-resistant (MDR) bacteria. In this study, we isolated and characterized a novel AMP, named Hyde C1, from the chicory plant (Cichorium intybus L.). Hyde C1 was purified using reverse-phase high-performance liquid chromatography (RP-HPLC) and determined to have a molecular weight of 3686.4 Da. It exhibits strong antibacterial activity against both Gram-positive (S. aureus ATCC 29213) and Gram-negative (E. coli ATCC 25922, P. aeruginosa ATCC 27853, A. baumannii ATCC 19606) bacteria, with minimum inhibitory concentrations (MICs) ranging from 2 to 16 µg/mL. Hyde C1 disrupts bacterial membranes, as evidenced by increased permeability, membrane depolarization, and scanning electron microscopy. Bioinformatic analysis revealed its amphipathic α-helical structure, with a high hydrophobic ratio (61%) and a net positive charge (+ 6), supporting its bactericidal mechanism. The peptide also demonstrated high stability under various pH, temperature, and salt conditions, along with low hemolytic and cytotoxic effects. These properties suggest that Hyde C1 is a strong candidate for development as a novel antimicrobial agent.